Abstract: Disclosed therein is a stator assembly including: a stator core (10) having a round base, a plurality of teeth radially formed along the outer circumferential surface of the base, and at least one connector bushing formed on the inner circumferential surface of the base; and an insulation coating layer (20) formed on the surface of the stator core, wherein the insulation coating layer (20) is coated to the outer diameter surfaces of the teeth of the stator core.

Abstract: A method for prevention or treatment of a cancer, comprising co-administering (a) an anti-c-Met antibody or an antigen-binding fragment thereof, and (b) at least one of lapatinib, regorafenib, vemurafenib or a combination thereof, to a subject in need thereof, and a pharmaceutical composition comprising (a) an anti-c-Met antibody or an antigen-binding fragment thereof, and (b) at least one of lapatinib, regorafenib, vemurafenib, or a combination thereof are provided.

Abstract: The present invention relates to a method for assembling a motor set that includes: coupling a rotor housing having a plurality of operating holes to a stator having shaft bushings with holes formed therein through the operating holes, thereby making the holes to be seen through the operating holes; coupling the holes of the stator associated with the rotor housing to stator assembly holes of a motor set assembly, the holes of the stator being aligned with the stator assembly holes of the motor set assembly; and inserting rivets into the holes through the operating holes and coupling the rivets to the stator assembly holes.

Abstract: A method of preventing and/or treating a cancer including co-administering a c-Met inhibitor and a beta-catenin inhibitor to a subject in need thereof, a pharmaceutical composition comprising a c-Met inhibitor and a beta-catenin inhibitor, and a kit comprising a pharmaceutical composition comprising a c-Met inhibitor, and a pharmaceutical composition comprising a beta-catenin inhibitor packaged together.

Abstract: A method of preventing and/or treating a cancer including co-administering a c-Met inhibitor and a c-Myc Inhibitor to a subject in need thereof, a pharmaceutical composition comprising a c-Met inhibitor and a c-Myc inhibitor, and a kit comprising a pharmaceutically effective amount of a c-Met inhibitor as an active ingredient, and a second pharmaceutical composition comprising a pharmaceutically effective amount of a c-Myc inhibitor as an active ingredient, packaged together.

Abstract: Disclosed herein are novel electrochromic materials. The electrochromic materials produce various colors. The electrochromic materials can be used to form red electrochromic layers in a simple manner. Therefore, the electrochromic materials are suitable for use in the fabrication of RGB full-color electrochromic devices. Also disclosed herein are electrochromic devices fabricated using the electrochromic materials.

Abstract: A target substance used for combination treatment with an anti-c-Met antibody, a pharmaceutical composition for combination administration for preventing and/or treating cancer including an anti-c-Met antibody and an inhibitor against the target substance as active ingredients, a method for preventing and/or treating cancer including co-administering an anti-c-Met antibody and an inhibitor against the target substance, and a method for screening a drug for preventing and/or treating cancer using the target substance.

Abstract: The present invention relates to a stator for a motor including: a stator core having an annular back yoke and a plurality of teeth; an upper insulator having an annular body portion formed correspondingly to the back yoke of the stator core and a plurality of teeth insulation portions formed correspondingly to the teeth of the stator core so as to cover the upper sides of the teeth of the stator core; a lower insulator having an annular body portion formed correspondingly to the back yoke of the stator core and a plurality of teeth insulation portions formed correspondingly to the teeth of the stator core so as to cover the upper sides of the teeth of the stator core; a plurality of insulation films each adapted to be inserted into the slot to cover the side of the stator core exposed to the inside of the slot between the upper insulator and the lower insulator; and coils adapted to be wound on the teeth of the stator core enclosed by the upper insulator, the lower insulator and the insulation films.

Abstract: Disclosed is a rotor housing for a motor. The rotor housing has a shaft bushing in the center thereof and includes a plurality of operating holes disposed at a defined position between an outer circumference of the rotor housing and the shaft bushing. The defined position corresponds to the position of a plurality of holes formed in a stator to be coupled to the rotor housing.

Abstract: Provided is a method for prevention or treatment of a cancer, comprising co-administering (a) an FGFR inhibitor and (b) an anti-c-Met antibody or antigen-binding fragment thereof to a subject in need thereof, wherein the anti-c-Met antibody or the antigen-binding fragment thereof specifically binds to an epitope comprising 5 or more contiguous amino acids within the SEMA domain of c-Met protein.

Abstract: Provided is a method of combination therapy for prevention or treatment of a cancer including or consisting essentially of co-administering sorafenib and an anti-c-Met antibody or an antigen-binding fragment thereof to a subject. The method of combination therapy can achieve an excellent synergistic effect and lower the effective dose of the anti-c-Met antibody, thereby enabling a more effective cancer treatment.

Abstract: A method of combination therapy for prevention and/or treatment of c-Met- and/or EGFR-induced diseases including co-administering a pharmaceutically effective amount of an EGFR antagonist and a pharmaceutically effective amount of an anti-c-Met antibody to a subject in need thereof is provided.

Abstract: Disclosed therein is a rotor for a motor. The rotor includes: a rotor core including an annular ring having a shaft hole formed at a central portion thereof, a plurality of yokes formed around the annular ring, and magnet insertion holes formed between the neighboring yokes; magnets respectively inserted into the magnet insertion holes; and a pair of rotor covers each having a ring plate, which has a shaft insertion hole formed at a central portion thereof, and a plurality of stoppers protrudingly formed around the ring plate. A pair of the rotor covers are joined to an upper portion and a lower portion of the rotor core in such a fashion that the stoppers are respectively located at side portions of the magnet insertion holes.

Abstract: An anti-c-Met antibody or antibody fragment and pharmaceutical composition comprising same, as well as a method for preventing and treating cancer by administering the antibody to a subject are provided.

Abstract: A method of identifying a cell sample or a subject suitable for treatment with an anti-c-Met antibody or antigen binding fragment thereof that specifically binds to an epitope within a SEMA domain of a c-Met protein by determining a Cbl concentration, a Cbl mutation, and/or a mutation of a site of c-Met for interaction with Cbl in a cell sample from a subject, as well as related compositions and methods.

Abstract: A method of identifying a cell sample or subject suitable for treatment with an anti-c-Met antibody or antigen-binding fragment thereof that specifically binds to an epitope within a SEMA domain of a c-Met protein by determining the presence of LRIG1 in a cell sample from the subject, as well as related methods and compositions.

Abstract: The present invention relates to a method for screening an anticancer agent using ROR?, the method comprising the steps of: culturing cells; bringing a potential substance into contact with the cells; determining whether the phosphorylation level of ROR? in the cells increases as compared to that in control cells (not brought into contact with the potential substance); and selecting the potential substance as an anticancer agent if the phosphorylation level of ROR? in the cells increases.

Abstract: Provided is a method of combination therapy for prevention or treatment of c-Met-induced or angiogenesis factor-induced diseases including co-administering an angiogenesis inhibitor and an anti-c-Met antibody or an antigen-binding fragment thereof to a patient.

Abstract: Disclosed is a rotor of a motor including: a cup-shaped rotor housing having a side wall portion formed along the outer peripheral surface thereof; a rotor core disposed inside the side wall portion of the rotor housing and having a plurality of U-shaped insertion grooves formed therealong; and a plurality of U-shaped magnets adapted to be inserted correspondingly into the plurality of U-shaped insertion grooves of the rotor core.

Abstract: Disclosed is a stator of a motor having a stator core having a plurality of teeth protruded therefrom and a slot formed between the adjacent teeth; and at least one or more L-shaped coupling members adapted to be attached to given positions on a side peripheral surface of the stator core, each L-shaped coupling member having a flat surface portion and a side wall portion, the flat surface portion 2a having a fastening hole formed thereon.